Literature DB >> 8746452

Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient.

R L West1, J M Lee, L E Maroun.   

Abstract

Aberrant expression of the amyloid precursor protein (APP) gene may contribute to the beta-amyloid deposition seen in Alzheimer's disease and Down syndrome patients. Genomic DNA was isolated from human brain tissue and digested with HpaII, an enzyme sensitive to CpG methylation. Southern-blot analysis revealed the absence of methylation at a site in the APP gene of an Alzheimer's disease subject. This site was methylated in a nondemented subject and a subject with a non-Alzheimer's type of dementia (Pick's disease). This is the first report of an epigenetic defect in an Alzheimer's disease patient and the observation suggests that hypomethylation of the APP gene may be one of several factors contributing to aberrant gene expression in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746452     DOI: 10.1007/BF02736773

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

Review 3.  Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.

Authors:  C Haass; D J Selkoe
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

Review 4.  Role of the beta-amyloid precursor protein in Alzheimer's disease.

Authors:  F Ashall; A M Goate
Journal:  Trends Biochem Sci       Date:  1994-01       Impact factor: 13.807

5.  Neuroanatomical localization and quantification of amyloid precursor protein mRNA by in situ hybridization in the brains of normal, aneuploid, and lesioned mice.

Authors:  C Bendotti; G L Forloni; R A Morgan; B F O'Hara; M L Oster-Granite; R H Reeves; J D Gearhart; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Human cytoplasmic superoxide dismutase cDNA clone: a probe for studying the molecular biology of Down syndrome.

Authors:  J Lieman-Hurwitz; N Dafni; V Lavie; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

7.  Amyloid precursor protein gene expression in neural cell lines: influence of DNA cytosine methylation.

Authors:  S Ledoux; J Nalbantoglu; N R Cashman
Journal:  Brain Res Mol Brain Res       Date:  1994-07

8.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

9.  The promoter of Alzheimer's disease amyloid A4 precursor gene.

Authors:  J M Salbaum; A Weidemann; H G Lemaire; C L Masters; K Beyreuther
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

10.  The ontogeny of allele-specific methylation associated with imprinted genes in the mouse.

Authors:  M Brandeis; T Kafri; M Ariel; J R Chaillet; J McCarrey; A Razin; H Cedar
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

View more
  66 in total

1.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

Review 2.  Folate and Alzheimer: when time matters.

Authors:  Margareta Hinterberger; Peter Fischer
Journal:  J Neural Transm (Vienna)       Date:  2012-05-25       Impact factor: 3.575

3.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 4.  DNA methylation impacts on learning and memory in aging.

Authors:  Liang Liu; Thomas van Groen; Inga Kadish; Trygve O Tollefsbol
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

Review 5.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

Review 6.  Epigenetic mechanisms of neurodegeneration in Huntington's disease.

Authors:  Junghee Lee; Yu Jin Hwang; Ki Yoon Kim; Neil W Kowall; Hoon Ryu
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

7.  Epigenetic changes in the progression of Alzheimer's disease.

Authors:  M A Bradley-Whitman; M A Lovell
Journal:  Mech Ageing Dev       Date:  2013-09-03       Impact factor: 5.432

Review 8.  Advances in epigenetics and epigenomics for neurodegenerative diseases.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 9.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 10.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.